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Several workers have observed the incidental occurrence of a viral disease in various 
strains  of transplantable  leukemias  in mice. Nelson  (1-4)  has fully described a  fil- 
terable agent causing acute hepatitis  in leukemic mice of the Princeton strain.  Al- 
though he made repeated efforts to keep the leukemia in passage, it was regularly lost 
after a few transfers. Marked pathological changes were noted in the livers of some of 
the mice which died, and a  filterable agent capable of inducing similar changes was 
obtained from the liver. A disease closely related to that described by Nelson had been 
found by Gledhill  and Andrewes (5, 6) in the Webster strain of VS mice, following the 
injection of liver filtrates from the Parks strain of mice. Later, it was discovered that 
the full expression of the disease was determined  by the presence of Eperythrozoon 
coccoides (7). This finding was subsequently confirmed by Nelson (4), who showed that 
the virulence of the hepatitis virus in Swiss mice--which have a high natural resistance 
to infection  by the  agent,--was  greatly enhanced  by combined infection with  the 
eperythrozoon. MacDowell eta/.  (8) had also reported the presence of a virus in line I 
leukemia that caused a mild illness in C58 mice in which the line was carried, but was 
fatal to Bagg albino mice in which the leukemia did not "take."  Somewhat similar 
diseases  caused by filterable agents were noted by De Bruyn (9) in animals bearing a 
transplantable lymphoma and by Law and Dunn (10)  in a subline of transplantable 
lymphatic leukemia L  1210 in dba mice. Although these workers (8-10) did not spe- 
cifically refer to a ,hepatitis,  the signs and symptoms they described are strikingly 
similar to our findings. 
The  present  report  describes  the  events  leading  up  to  the  isolation  of  a 
virus  causing an hepatic  disease  in  mice  carrying line  I  leukemia.  The  signs 
during life and the pathological features of the disease which followed upon the 
administration  of urethane  or  methylformamide  and  led  to  isolation  of  the 
virus, are here presented as also are certain observations on host susceptibility. 
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Health Service, the American Cancer Society, and the Damon Runyon Memorial Fund for 
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Materials and Methods 
The mice used were F1  hybrids of C58  X  Bagg albino crosses  (F1);  pure Bagg albino; 
Webster strain Swiss mice; and Princeton Rockefeller Institute mice (PRI). They were from 
4 to 6 weeks of age. 
The original line I leukemia (11) carried in C58 mice was supplied to the Sloan-Kettering 
Institute  by Dr. E. C. MacDowell in 1950 and since then has been kept in passage  by the 
intraperitoneai injection of ten to twenty million cells from minced spleen of leukemic do- 
nors.  There was a  take of approximately 98 per cent,  and  the survival time was approxi- 
mately 5 to  7  days  (Fig.  1). 
When it was noted that urethane and  methyiformamide prolonged the survival time of 
mice with leukemia  (12),  attempts were made to start additional leukemic sublines which, 
it was hoped,  would eventually become refractory to the treatment. One urethane and  one 
methyiformamide treated subline were started from the original line I. F1  mice previously 
inocuiated with leukemia were injected with urethane  or methylformamide respectively, in 
doses sufficient  to delay the leukemic process.  Urethane was  uniformly given in  doses of 
I000 mg./kg., and methyiformamide in doses of 400  mg./kg. In the dosages used, urethaae 
and  methylformamide did not cause any pathological changes in the livers of the control 
animals.  "Pretreatment" with urethane was given 120, 72, and  24 hours before inoculation 
with leukemia.  "Treatment" was given at 48  hour intervals beginning 24 hours  after in- 
oculation.  One animal from each group was sacrificed  shortly before its death was expected 
and  a  suspension  of its spleen was  transferred  to new animals which  were treated  in the 
manner described. Each such passage was designated a transfer generation. No morphological 
changes from the original line I--an  undifferentiated "stem  cell" leukemia--were detected 
in the treated subllnes. 
After several such transfer generations in treated animals, the survival time of the mice, 
which had been significantly prolonged in the early transfers, was found to have been short- 
ened as compared with the survival time of the untreated leukemic controls. It was noticed 
that the treated mice (although dying earlier) had smaller lymph nodes, spleens,  and livers 
than  did the untreated  controls with the original line I  leukemia.  Shortly  thereafter,  the 
mice in the methylformamide-treated subline started to die 2 to 3 days after inoculation, and 
presented no macroscopic or microscopic  evidence of leukemia at death. All of them exhibited 
ivory-pale livers thickly covered with hemorrhagic spots. Microscopically, these livers showed 
extensive areas of necrosis.  Since essentially the same picture was found in untreated control 
mice inoculated with minced splenic or hepatic tissue of the urethane- or methylformamide- 
treated sublines,  a bacterial infection was suspected and numerous cultures of the organs of 
the diseased  mice were taken.  These were either negative or inconclusive. The mice were 
further treated with various antibiotics, all of which proved ineffective. It was at this point 
that a  viral etiology of the disease was considered and filtrates were made of the organs of 
the sick mice. 
The liver and  spleen from each animal were ground  in approximately  15  ml. of saline. 
The ground tissue suspension  was sedimented at low speed (500 to 1000 ~a,.K.)  for 5 to 10 
minutes. The supernatant fluid was then filtered through Selas 02 or 03 candles. It was found 
that the hepatic disease could be transmitted in the absence of leukemia to mice inoculated 
intraperitoueally with 0.1 to 0.5 cc. of the filtrate. 
EXPEI~NTAL 
Classification of the Disease 
The disease has been arbitrarily  classified as:  (a)  acute if a  high percentage 
of  the  F1  hybrid  mice died after  inoculation with  the  filtrate;  (b)  subacute if H.  BRAUNSTEINER  AND  C.  FRIEND  667 
only a low percentage of the F1 mice died, although a high percentage of the 
BALB mice died; and (c) latent if  neither the  F1 nor BALB died or became 
ill. 
(a)  The  Acute  Disease.--The  acute  disease  appeared  in  the  methylform- 
amide-treated subline after twelve transfer generations, killing the mice within 
4 days. (In the original line I  this compound prolonged life for 11 to 12 days.) 
At  the  same  time,  all signs of leukemia were lost. The hepatitis,  however, 
could be transferred serially by the injection of either a  suspension of minced 
liver and spleen or a filtrate of these organs and has thus far retained its viru- 
lence without further use of the drug. The results of the inoculation of the 
filtrate into F1, BALB, and the PRI strains of mice are presented in Table I. 
Prior to death,  the mice showed the following symptoms, which are charac- 
TABLE I 
HosSSmc~tibil~y  ~theActatHep~Distase 
Strain  Age  No. inoculated  No. dead  Average  survival  time 
FI 
FI 
BALB 
BALB 
PRI 
Weanlings* 
Adults:l: 
Weanlings 
Adults 
Young adults§ 
10 
12 
10 
12 
20 
10 
12 
10 
12 
20 
days 
3.1 
3.6 
3.4 
3.7 
3.6 
Inoculum: 0.3 cc. intraperitoneally  of filtrate of liver and spleen of acutely diseased mice. 
* 12 to 15 gin. 
18 to 25 gin. 
§13tolSgm. 
teristic  of  the disease: marked, weight loss,  inactivity, roughing of the fur, 
tremors, and dark urine. At autopsy, the thymus and lymph nodes were gen- 
erally reduced in size,  but no constant relation was found for the  size  and 
weight of the spleen. A few animals showed focal hemorrhages in the  lungs. 
The principal changes were found in the liver, which was pale and varied from 
light pink  to almost white. In addition, it contained numerous  hemorrhagic 
areas.  On  microscopic examination,  an  almost  complete  breakdown  of  the 
parenchymal cells was noted. Occasionally, a moderate leukocytic infiltration 
was present. The large vessels were frequently distended with blood (Figs. 2 
and  3).  In  a  subsequent  publication  a  complete  pathological  study of  the 
organs of affected mice will be presented. 
(b) The Subacute Disease.--The  subacute disease appeared in the urethane- 
treated subline after eleven transfer generations and in the methylformamide- 
treated subline after seven transfer generations. The mice died within 6 to 7 
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from the livers and spleens of subacutely ill mice of the urethane-treated subline 
into several strains of mice are shown in Table II. The average survival time 
was longer  than  that  observed in  the acute  disease,  but  the  signs  of illness 
and the autopsy findings were identical  (Figs.  4  and 5).  It can be seen that 
the various strains tested differ markedly in susceptibility to the agent. The 
PI~  appear to be highly sensitive--a finding also noted by Nelson  (2)  with 
his  hepatitis  virus.  In general,  infants and weanlings were  more  susceptible 
than adults. 
All mice which  survived showed more or less marked signs of the disease 
between  the  6th  and  14th  days  after  inoculation.  The most  sensitive  and 
TABLE II 
Host Susceptibility to the Subacute Hepatic,  Disease 
Strain 
F1 
F1 
F1 
BALB 
BALB 
Swiss 
Swiss 
PRI 
Age 
Infants 
Weanlings* 
Adults$ 
Weanlings 
Adults 
Infants 
Young adults§ 
Young adults 
No.~o~ht~ 
5 
10 
60 
10 
20 
8 
20 
20 
No. dead 
5 
7 
3 
10 
14 
8 
6 
20 
Average survivs] 
time 
days 
5.8 
5.5 
7.2 
5.2 
6.9 
6.8 
5.8 
5.2 
Inoculum: 0.3 cc. intraperitoneaUy of filtrate of liver and spleen from subacutely diseased 
mfce. 
* 12 to 15 gm. 
~: 18 to 25 gin. 
§ 14 to 18 gm. 
constant sign was a weight loss of up to 20 per cent. Approximately 3 weeks 
after inoculation the surviving mice had reached or passed their former weight 
and were fully recovered. If the animals were sacrificed at the height of the 
non-lethal disease, focal areas of parenchymal damage were found on micro- 
scopic examination in the liver. No pathological changes were found in animals 
that recovered from the illness and that were subsequently sacrificed. 
(c) The Latent Disease.--A latent disease was found in the original line I. A 
filtrate of livers and spleens of these animals was not lethal to infant or adult 
F1 or BALB mice, nor did these animals show any signs of illness. Evidence, 
however, is presented below to support the presence of a  latent virus. 
The Development of Immunity to the Virus 
It was of interest  to determine whether  the mice which  had  survived  the 
hepatic disease had developed sufficient antibody to resist reinfection with the 
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(a) Immunity after Subacute Infection.--TwenW adult F1  mice which had recovered 22 
days after inoculation were challenged by reinoculation of a  filtrate from animals with the 
acute disease. None of these mice died or showed signs of illness, whereas  six control non- 
immune  mice died within  4  days (Table  III). Essentially the same results  were obtained 
with ten BALB mice which had survived  the subacute  hepatitis  and were  then challenged 
with the virus from subacutely diseased mice. 
(b) Immunity after Latent Infectlon.--Twenty  BALB mice were injected  with a filtrate 
from the livers and spleens of mice with the original line I leukemia. None of these died or 
showed signs of the disease. 18 days later  these mice were reinoculated with a filtrate  from 
subacutely ill mice. Again, none of these animals died or showed signs of illness; whereas six 
out of ten control animals which had received the same filtrate died, and the surviving  four 
showed marked signs of the disease and a 15 per cent weight loss (Table IID. 
The fact that  the initial  infection with  material  from  line  I  leukemia  had 
provided sufficient antibody to protect  against  infection  with  the  virus from 
TABLE HI 
Tke Devdopment of Immunity after Infection 
Strain  No. inoculated  Initial infection  Challenged  with:  No. surviving 
F1  20  Subacute  Acute  20 
F1  6  None  Acute  0 
BALB  20  Latent  Subacute  20 
BALB  10  None  Subacute  4 
Inoculum: 0.3 cc. intraperitoneally  of filtrate containing virus. 
the subacute disease is interpreted as evidence for the presence of a latent virus 
carried in line I  leukemia. 
The Influence of Uretkane  and Metkylforraamide  on the Evolution of the Disease 
It  has  been  shown  that  only three  out  of sixty  F1  adults  died  from  the 
subacute disease transmitted  by the filtrate  (Table I). If urethane or methyl- 
formamide were administered to these mice, the severity of the disease increased 
greatly. The results  of an experiment  in which one group of F1 were treated 
with three doses of urethane after inoculation with the filtrate; a  second group 
pretreated  with  three  doses,  infected,  and  then  given  three  further  doses  of 
the drug; and a third non-treated control group that received only the filtrate-- 
are summarized in Table IV. Pretreatment and posttreatment, or posttreatment 
alone,  caused  a  considerable  increase  in  mortality.  All  animals  showed  the 
characteristic  signs  of the  disease,  and  at  autopsy large necrotic areas  were 
found in the livers. 
For further investigation of the possibility of a  latent asymptomatic disease 
in the line I leukemia, twelve F1 adult mice were treated with urethane  before 
and  after  inoculation  with  a  filtrate  of liver  and  spleen  from mice  with  the 
original  line  I  leukemia.  Seven of the twelve animals died  with  typical  liver 
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effect was observed in F1 mice after being pre- and posttreated with methyl- 
formamide. Seven out of ten mice died when injected with the filtrate from 
the line I leukemia. None of the infected non-treated controls or the uninfected 
drug control mice showed any sign of disease. This was interpreted as further 
evidence that the agent is latent in the original line I, but manifests itself only 
if a supplementary factor is present. Whether the role of this factor is prepara- 
tory, inciting, or damaging remains to be determined. It should be emphasized, 
however,  that  in  the  dosages  used  urethane  or  methylformamide did  not 
cause any pathological changes in the livers of control animals. 
Since mice which had overcome the subacute disease had been found to be 
immune to reinfection, fifteen F1 adults which had survived inoculation with 
the filtrate from subacutely diseased animals 22 days previously were treated 
TABLE IV 
The Effeds of Urahane an the Subazute Disease in FI Adult Mice 
No.  animals 
20 
20 
20 
Dose urethane prior to 
filtrate injection 
0 
0 
1000 mg./kg. X 3 
Dose urethane after 
filtrate injection 
0 
1000 mg./kg. X 3 
1000 mg./kg. X 3 
No. dead 
1 
6 
19 
Average 
survival time 
~ys 
7.0 
7.2 
7.2 
Inoculum: 0.3 cc. intraperitoneslly  of filtrate of liver and spleen from subacutely  diseased 
mice. 
with urethane before and after reinfection with  the filtrate. Eight of these 
fifteen mice died from the disease and all of the others had shown marked signs 
of the disease, indicating that the immunity established by the initial infection 
was broken down by the urethane treatment. 
Finally, two new sublines treated with either urethane or methylform-mlde 
were started to check whether the enhancement of the agent through passage 
in the treated mice could be regularly reproduced. In this second series,  the 
subacute disease developed after eight transfer generations in the urethane- 
treated subline and appeared after six transfer generations in the methylform- 
amide-treated subline. An acute disease had meanwhile developed in the original 
urethane-treated subline after twenty-five passages. 
"Freeing" the Leukemic Cells from the Agent 
Leukemic cells  of  the  urethane-treated  subline  that  carried  the  subacute 
disease were passed through four transfer generations in F1 mice which had 
survived infection with the disease. After passage in these immune animals, the 
spleens and livers of the mice dying of leukemia had attained the same size 
and color as those in the original line I leukemia and no sign of hepatic necrosis H.  BRAUNSTEINER  AND  C.  FRIEND  671 
could be observed.  Filtrates of livers and spleens from these animals caused 
neither death nor illness when inoculated into  F1  or BALB. When, however, 
the F1 were pretreated and then posttreated with urethane after inoculation 
with these filtrates, five out of ten mice died, thus indicating that the cells 
were not completely freed of the agent, which had merely reverted to its latent 
form by passage in immune mice. 
DISCUSSION 
There is strong evidence that the acute form of the hepatic disease described 
in this paper is closely related, if not identical, with that described by Nelson 
(1-4). The manifestations during life and the pathological picture are strikingly 
similar, with the exception that we have never detected eperythrozoa in the 
peripheral blood of our mice. A close relation seems to exist also to the disease 
reported by Gledhill et al.  (5-7). The subacute form appears to correspond to 
the disease noted by MacDowell et al.  (8,  13) and by Law and Dunn (10),  al- 
though Law and Dunn's disease later turned spontaneously to a  more acute 
form. 
It is possible that the agent we have been investigating is the original virus 
described by MacDowell, since line I  leukemia maintained in Sloan-Kettering 
Institute was supplied by his laboratory. We have been unable to free the leu- 
kemic cells from the virus, but have succeeded in inducing a change to a latent 
asymptomatic form. Since we have employed the same methods as Taylor and 
MacDowell (13),  it is conceivable that the line was never  completely freed of 
the agent, which has been carried for several years in its latent form. 
Whatever differences there may be between our findings and those of other 
workers  (8,  9,  10,  13)  in regard to the response of the lymphatic system to 
infection with the agent they are not incompatible nor do they necessarily indi- 
cate different diseases. We have encountered similar differences between the acute 
and subacute forms. There seems to be a direct correlation between the virulence 
of the agent and the lymphopenic changes. In general, when the virulence of 
the agent is enhanced and the disease becomes acutely lethal, there is not only 
a  marked hypoplasia of the lymphatic system, but  an absence of leukemia 
(4, 8, 10). This constitutes a very interesting, but as yet obscure, relationship 
of the latter to the hepatic disease. It is conceivable that the leukemic cells, 
which presumably act  as  host of the virus,  are  rapidly destroyed when its 
virulence is enhanced. 
The agent has been found primarily in transplantable mouse leukemias in 
all the instances cited, except one in which its origin was not clear (5).  While 
the possibility exists that a  contaminating agent may have been passed along 
with the serial transfer of leukemic cells,  the fact that this agent has been in 
each case hepatitis virus is most suggestive. It will be of interest to examine 
not only other lines of established leukemias, but also new lines of spontaneous 672  LATEh"r  VIRAL  HEPATITIS  IN  LEUKEMIC  ]~ICE 
leukemias for the presence of similar agents.  Such investigations  might reveal 
more than just a coincidental relationship between this group of hepatic diseases 
and leukemia. 
The principal  result of these investigations  is the demonstration of the en- 
hancement of  the  virulence  of a  filterable  agent by treating each  transfer 
generation  with urethane or methylformamide. It should be noted that, once 
the enhancement of virulence was obtained, it was permanent and independent 
of further treatment with  these  drugs.  It  thus  resembled  the  spontaneous 
change  in virulence  which  has been  observed  occasionally  in  this group  of 
diseases  (10, 13). Treatment with urethane has been  found to increase  the 
severity of infection with pneumonia virus of mice, but no mention is made of 
an  enhanced virulence  of  the  virus  itself  (14). The  permanent,  enhanced 
virulence which we obtained may be due either to a direct action of urethane 
or methylformamide on the agent or to one on the host. There is no evidence 
for the first possibility.  The present concept  of the relationship  between  the 
host and the virus makes the second possibility more likely. 
Urethane  may  cause  liver  damage  (15, 16), and  methylformamide has 
been proven to be hepatotoxic (17, 18). It is, therefore, conceivable that treat- 
ment with these compounds leads to liver damage,  which is overcome, under 
ordinary conditions,  but which  in the case of the latent infection  gives  the 
agent a better opportunity to penetrate and multiply in the liver cells. 
Another hypothesis to consider is an inhibition of antibody formation or of 
some other general defense mechanism during the treatment with urethane or 
methylformamide.  Preliminary experiments have shown that nitrogen mustard, 
which inhibits the formation of antibody (19), may have the same effect in 
increasing the virulence of the virus as urethane and methylformamide. Cor- 
tisone, thus far, has proved ineffective in this respect. 
The method of pretreating and posttreating animals with urethane or methyl- 
formamide may prove useful in investigating other virus diseases. An attempt 
to adapt human hepatitis virus to mice which had been given urethane in their 
drinking water has been reported (20). 
SUMMARY 
An hepatic disease caused by a filterable agent carried  in leukemic mice is 
described. Ordinarily the virus remains latent and asymptomatic. If, however, 
the mice are treated with urethane or methylformamide  before and after virus 
inoculation,  the disease becomes manifest and is characterized  by extremely 
marked liver necrosis. 
Infant mice, a  large percentage  of weanlings, and adult Bagg albino  mice 
are killed when injected with a filtrate from organs of diseased animals. Adult 
F1 and Swiss mice show signs of the disease but generally recover. They suc- 
cumb,  however,  when  simultaneously treated with urethane or methylform- H. BRAUNSTEINER AND C.  FRIEND  673 
amide.  By continuing the  treatment  of consecutive  transfer generations an 
acute disease can be induced which finally kills all adult F1 mice without the 
treatment. At this stage the original leukemia may be lost. 
Mice which have recovered from the subacute disease are resistant to the 
acute disease, and mice injected with the latent form of the agent are immune 
to the subacute disease. However, even immunized animals lose their resistance 
if they are treated with urethane. The acute or subacute disease can be reduced 
to the latent stage by passing the agent through several generations of im- 
munized animals. 
The relationship of this hepatitis virus of mice to viruses causing similar 
diseases is discussed, as is the possibility that these agents are closely related, 
if not identical. 
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EXPLANATION OF PLATES 
Mouse livers. Hematoxylin and eosin. X  120. 
PLATE 64 
FIG.  1. Control, 4 days after inoculation with cells of Line I  leukemia. Leukemic 
cells cufl~ng major vessels and lying free in sinusoids.  No necrosis. 
FIC. 2. Urethane treated, 4 days after inoculation with leukemia. Acute hepatitis. 
Marked diffuse necrosis. 
FIG. 3. Untreated, 5 days after inoculation with 0.1  cc. of 10  -1 dilution of filtrate. 
Acute hepatitis in the absence of leukemia. Marked diffuse necrosis. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 100  PLATE 64 
(Braunsteiner and Friend: Latent viral hepatitis in leukemic mice) PLATE 65 
FIC. 4. Urethane treated, 5 days after inoculation with leukemia. Subacute hepati- 
tis. Focal necrosis. 
FIG. 5.  Untreated mouse, 8 days after inoculation with 0.1  cc. of  10  -1 dilution of 
filtrate. Subacute hepatitis in the absence of leukemia. Focal necrosis. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  100  PLATE  65 
(Braunsteiner and Friend: Latent viral hepatitis in leukemic mice) 